Compound class:
Synthetic organic
Comment: Pelubiprofen is a nonsteroidal anti-inflammatory type compound [6]. Structurally it is an aryl propionic acid derivative, like ibuprofen. The INN-defined agent is a racemic mixture of enantiomers. We show the structure without specified stereochemistry to represent the mixture. Pelubiprofen is described as a prodrug of 2-arylpropionic acid with modest selectivity for COX2 [3].
|
|
Immunopharmacology Comments |
Whilst the main mechanism of action of pelubiprofen is inhibition of the cyclooxygenase (COX) enzymes which produce pro-inflammatory mediators such as PGE2, it is also reported to inhibit the inflammatory TAK1-IKK-NF-κB pathway [5]. |
Immunopharmacology Disease | |||
Disease | X-Refs | Comment | References |
Rheumatoid arthritis |
Disease Ontology:
DOID:7148 OMIM: 180300 |
Results from a Phase 3 clinical trial that compared 6 weeks treatment with pelubiprofen to celecoxib treatment, indicate that this novel drug is as effecive as the comparator. However, patients given pelubiprofen suffered more gastrointestinal adverse effects than did the celecoxib cohort. | 3 |